Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists01:23

Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists

Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Internalized Components of Membrane Attack Complexes Disrupt Proteostasis and Acquire Alarmin-Like Properties.

bioRxiv : the preprint server for biology·2026
Same author

Immunomodulation by platelet-derived DKK1: potential for controlling disease and pathology in leishmaniasis and implications for other infectious diseases.

Frontiers in immunology·2026
Same author

Metabolic control of smooth muscle cell phenotype switching in atherosclerosis.

bioRxiv : the preprint server for biology·2026
Same author

Author Correction: A ZFYVE21-Rubicon-RNF34 signaling complex promotes endosome-associated inflammasome activity in endothelial cells.

Nature communications·2026
Same author

Increased medial collagen enhances aortic resilience against mural delamination from hydraulic fracturing.

bioRxiv : the preprint server for biology·2026
Same author

Hydraulic fracturing-induced delamination and extravasation extends medial damage beyond the false lumen in aortic dissection.

bioRxiv : the preprint server for biology·2026

相关实验视频

Updated: May 31, 2026

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

过氧体增殖器激活的受体-γ 主动剂在体内阻止由全活性T细胞诱导的人类动脉重塑.

Zuzana Tobiasova1, Lufeng Zhang, Tai Yi

  • 1Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA.

Circulation
|June 22, 2011
PubMed
概括

过氧体增殖器激活受体-玛 (PPARγ) 激动剂在通过抑制人类T细胞反应来预防血管移植排斥方面表现有前途. 这些发现表明了对移植排斥的潜在新疗法.

更多相关视频

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

相关实验视频

Last Updated: May 31, 2026

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics
08:42

A Rat Carotid Balloon Injury Model to Test Anti-vascular Remodeling Therapeutics

Published on: September 19, 2016

Mouse Models for Graft Arteriosclerosis
07:37

Mouse Models for Graft Arteriosclerosis

Published on: May 14, 2013

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis
07:05

Mouse Model of Alloimmune-induced Vascular Rejection and Transplant Arteriosclerosis

Published on: May 17, 2015

科学领域:

  • 免疫学 免疫学 免疫学
  • 移植生物学 移植生物学
  • 药理学 药理学是指药理学的学科.

背景情况:

  • 过氧体增殖器激活的玛受体 (PPARγ) 配体具有抗炎性质.
  • 全基性T细胞反应驱动血管移植排斥,导致移植损失.
  • 动物研究表明PPARγ激动剂可能会防止血管排斥,但人类的反应仍然不清楚.

研究的目的:

  • 研究PPARγ激动剂对人类血管移植排斥的影响.
  • 确定PPARγ在人类T细胞对异性血管细胞反应中的作用.

主要方法:

  • 在免疫缺陷小鼠中的人类血管移植排斥模型,使用人类动脉和全源人类外周血液单核细胞.
  • 使用PPARγ激动剂 (15-deoxy-prostaglandin-J(2),西格利塔,皮格利塔) 和一种PPARγ激动剂 (GW9662).
  • 评估内脏厚,T细胞透,炎症性细胞因子水平,以及体外T细胞增殖和迁移.

主要成果:

  • PPARγ激动剂显著降低了亲密扩张,T细胞透和炎症性细胞因子水平.
  • PPARγ抗剂GW9662可以逆转PPARγ抗剂的保护作用.
  • 在体外,皮奥格利塔抑制了抗原诱导的T细胞增殖和超内皮细胞迁移.

结论:

  • 在血管移植排斥模型中,PPARγ激动剂有效地抑制了全基性人类记忆T细胞反应.
  • PPARγ激动剂代表了治疗血管移植排斥的潜在治疗策略.